That is, regardless of whether the biosimilar biological product meets the definition of a Part B rebatable drug or whether a rebate amount is owed for such biosimilar biological product for that applicable calendar quarter, CMS will apply the 75 percent reduction in the total rebate amount as set forth in 427.402(b)(1), even if there is no rebate amount owed to reduce

Since this is an intramuscular injection (IM) and patient supplies the vitamin B12: Use 99212-25 for the physician office visit and modifier 25 for significant service Use 90460 or 90471 for administration of vaccine or injectable biological substance Use J3420 for vitamin B12 injection code Answer options: a) 99212-25, 90460, J3420 correct - includes office visit with modifier, proper administration code for injection, and drug code b) 99211-25, 90471, J3420 (99211 is a lower E/M code, possible but less detailed) c) 99211-25, 96372 (no drug code, so incomplete) d) 99212-25, 96373 (96373 is for IV infusions, not IM injection, and no drug code) Correct answer: a) 99212-25, 90460, J3420 Question 44: Reporting Colonoscopy Biopsy with Multiple Specimens Patient had colonoscopy with biopsy of 2 polyps
The effects of the P-Shot can last up to 18 months before a repeat injection is needed
These documents typically summarize analytical methods used during quality control processes, such as chromatographic purity analysis or molecular mass confirmation